Point72 Hong Kong’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-32,895
Closed -$4.19M 658
2025
Q1
$4.19M Buy
+32,895
New +$5.06M 0.27% 91
2021
Q1
Sell
-3,059
Closed -$586K 2140
2020
Q4
$586K Buy
+3,059
New +$557K 0.03% 659
2020
Q3
Sell
-6,639
Closed -$821K 1474
2020
Q2
$821K Buy
+6,639
New +$781K 0.09% 248
2020
Q1
Sell
-926
Closed -$86K 1286
2019
Q4
$86K Sell
926
-498
-35% -$41.8K 0.02% 556
2019
Q3
$109K Buy
+1,424
New +$125K 0.03% 436
2019
Q2
Sell
-60
Closed -$4K 1359
2019
Q1
$4K Buy
60
+34
+131% +$1.96K ﹤0.01% 840
2018
Q4
$1K Buy
+26
New +$1.52K ﹤0.01% 812
2017
Q4
Sell
-3,690
Closed -$141K 1047
2017
Q3
$141K Buy
+3,690
New +$155K 0.1% 93
2017
Q1
Sell
-83
Closed -$3K 931
2016
Q4
$3K Buy
+83
New +$2.57K ﹤0.01% 755

Other funds holding RGEN

Point72 Hong Kong's RGEN Position: Q2 2025 in Review

Point72 Hong Kong sold out of Repligen (RGEN) in Q2 2025, closing a stake of 32,895 shares — an estimated $4.19M sold.

Point72 Hong Kong first reported a position in RGEN in Q4 2016 and held it in 9 quarters. The position peaked at $4.19M in Q1 2025. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • Point72 Hong Kong reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 32,895 Repligen shares in Q2 2025, an estimated $4.19M.
  • Point72 Hong Kong first reported a position in Repligen in Q4 2016 and held it in 9 quarters.
  • Point72 Hong Kong's Repligen position peaked at $4.19M in Q1 2025.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Point72 Hong Kong's 13F filing for Q2 2025, filed 14 Aug 2025.